![]() | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
| "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> SPAC List: List of Special Purpose Acquisition Companies |
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2020-09-01 Purchase | 2020-09-02 4:53 pm | Oncternal Therapeutics Inc. | ONCT | CARTER MICHAEL G Director | 71,429 | $2.1 | $150,001 | 71,947 (Direct) | View |
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2019-09-12 Option Award | 2020-07-31 9:05 pm | N/A 2029-09-12 | Oncternal Therapeutics Inc. | ONCT | AKER HAZEL M Legal Counsel | 150,000 | $0 | 150,000 (Direct) | View |
2020-03-17 Option Award | 2020-07-31 9:05 pm | N/A 2030-03-17 | Oncternal Therapeutics Inc. | ONCT | AKER HAZEL M Legal Counsel | 11,080 | $0 | 11,080 (Direct) | View |
2019-09-12 Option Award | 2020-07-31 9:05 pm | N/A 2029-09-12 | Oncternal Therapeutics Inc. | ONCT | AKER HAZEL M Legal Counsel | 150,000 | $0 | 150,000 (Direct) | View |
2020-01-07 Option Award | 2020-07-31 9:05 pm | N/A 2030-01-07 | Oncternal Therapeutics Inc. | ONCT | BREITMEYER JAMES B CEO | 22,000 | $0 | 22,000 (Indirect) | View |
2020-03-17 Option Award | 2020-07-31 9:05 pm | N/A 2030-03-17 | Oncternal Therapeutics Inc. | ONCT | BILINSKY IGOR Chief Business Officer | 12,690 | $0 | 12,690 (Direct) | View |
2019-09-12 Option Award | 2020-07-31 9:05 pm | N/A 2029-09-12 | Oncternal Therapeutics Inc. | ONCT | CARTER MICHAEL G Director | 30,000 | $0 | 30,000 (Direct) | View |
2020-03-17 Option Award | 2020-07-31 9:05 pm | N/A 2030-03-17 | Oncternal Therapeutics Inc. | ONCT | BREITMEYER JAMES B CEO | 66,890 | $0 | 66,890 (Direct) | View |
2020-06-11 Option Award | 2020-07-31 9:05 pm | N/A 2029-06-11 | Oncternal Therapeutics Inc. | ONCT | Cho Man Director | 15,000 | $0 | 15,000 (Direct) | View |
2019-12-18 Option Award | 2020-07-31 9:05 pm | N/A 2029-12-18 | Oncternal Therapeutics Inc. | ONCT | Cho Man Director | 30,000 | $0 | 30,000 (Direct) | View |
2019-08-26 Option Award | 2020-07-31 9:05 pm | N/A 2029-08-26 | Oncternal Therapeutics Inc. | ONCT | Hsu Frank J. Chief Medical Officer | 150,000 | $0 | 150,000 (Direct) | View |
2020-03-17 Option Award | 2020-07-31 9:05 pm | N/A 2030-03-17 | Oncternal Therapeutics Inc. | ONCT | Hsu Frank J. Chief Medical Officer | 16,280 | $0 | 16,280 (Direct) | View |
2019-09-12 Option Award | 2020-07-31 9:05 pm | N/A 2029-09-12 | Oncternal Therapeutics Inc. | ONCT | KISNER DANIEL L Director | 30,000 | $0 | 30,000 (Direct) | View |
2020-06-11 Option Award | 2020-07-31 9:05 pm | N/A 2030-06-11 | Oncternal Therapeutics Inc. | ONCT | KISNER DANIEL L Director | 15,000 | $0 | 30,000 (Direct) | View |
2019-09-12 Option Award | 2020-07-31 9:05 pm | N/A 2029-09-12 | Oncternal Therapeutics Inc. | ONCT | HALE DAVID F Director | 40,000 | $0 | 40,000 (Direct) | View |
2019-09-12 Option Award | 2020-07-31 9:05 pm | N/A 2029-09-12 | Oncternal Therapeutics Inc. | ONCT | Liu Yanjun Director | 30,000 | $0 | 30,000 (Direct) | View |
2019-09-12 Option Award | 2020-07-31 9:05 pm | N/A 2029-09-12 | Oncternal Therapeutics Inc. | ONCT | BREITMEYER JAMES B CEO | 100,000 | $0 | 100,000 (Direct) | View |
2019-09-12 Option Award | 2020-07-31 9:05 pm | N/A 2029-09-12 | Oncternal Therapeutics Inc. | ONCT | THEUER CHARLES Director | 30,000 | $0 | 30,000 (Direct) | View |
2019-09-12 Option Award | 2020-07-31 9:05 pm | N/A 2029-09-12 | Oncternal Therapeutics Inc. | ONCT | VINCENT RICHARD G CFO | 75,000 | $0 | 75,000 (Direct) | View |
2020-06-11 Option Award | 2020-07-31 9:05 pm | N/A 2030-06-11 | Oncternal Therapeutics Inc. | ONCT | Nakanishi Xin Director | 15,000 | $0 | 15,000 (Direct) | View |
2019-09-09 Option Award | 2020-07-31 9:05 pm | N/A 2029-09-09 | Oncternal Therapeutics Inc. | ONCT | BILINSKY IGOR Chief Business Officer | 150,000 | $0 | 150,000 (Direct) | View |
2020-03-17 Option Award | 2020-07-31 9:05 pm | N/A 2030-03-17 | Oncternal Therapeutics Inc. | ONCT | VINCENT RICHARD G CFO | 35,120 | $0 | 35,120 (Direct) | View |
2020-06-11 Option Award | 2020-07-31 9:06 pm | N/A 2030-06-11 | Oncternal Therapeutics Inc. | ONCT | CARTER MICHAEL G Director | 15,000 | $0 | 15,000 (Direct) | View |
2020-06-11 Option Award | 2020-07-31 9:06 pm | N/A 2030-06-11 | Oncternal Therapeutics Inc. | ONCT | HALE DAVID F Director | 22,500 | $0 | 22,500 (Direct) | View |
2019-09-05 Option Award | 2020-07-31 9:06 pm | N/A 2029-09-05 | Oncternal Therapeutics Inc. | ONCT | Kaufmann Gunnar F. Chief Scientific Officer | 150,000 | $0 | 150,000 (Direct) | View |
2019-09-12 Option Award | 2020-07-31 9:06 pm | N/A 2029-09-12 | Oncternal Therapeutics Inc. | ONCT | LARUE WILLIAM R Director | 30,000 | $0 | 30,000 (Direct) | View |
2019-09-12 Option Award | 2020-07-31 9:06 pm | N/A 2029-09-12 | Oncternal Therapeutics Inc. | ONCT | Nakanishi Xin Director | 30,000 | $0 | 30,000 (Direct) | View |
2020-03-17 Option Award | 2020-07-31 9:06 pm | N/A 2030-03-17 | Oncternal Therapeutics Inc. | ONCT | Kaufmann Gunnar F. Chief Scientific Officer | 14,260 | $0 | 14,260 (Direct) | View |
2020-06-11 Option Award | 2020-07-31 9:06 pm | N/A 2030-06-11 | Oncternal Therapeutics Inc. | ONCT | Wills Robert James Director | 15,000 | $0 | 15,000 (Direct) | View |
2020-06-11 Option Award | 2020-07-31 9:06 pm | N/A 2029-06-11 | Oncternal Therapeutics Inc. | ONCT | LARUE WILLIAM R Director | 15,000 | $0 | 15,000 (Direct) | View |
2020-06-11 Option Award | 2020-07-31 9:06 pm | N/A 2030-06-11 | Oncternal Therapeutics Inc. | ONCT | THEUER CHARLES Director | 15,000 | $0 | 15,000 (Direct) | View |
2019-09-12 Option Award | 2020-07-31 9:06 pm | N/A 2029-09-12 | Oncternal Therapeutics Inc. | ONCT | Wills Robert James Director | 30,000 | $0 | 30,000 (Direct) | View |
2021-01-27 Option Award | 2021-01-28 8:00 pm | N/A 2031-01-27 | Oncternal Therapeutics Inc. | ONCT | MAZANET ROSEMARY Director | 30,000 | $0 | 30,000 (Direct) | View |
2021-02-11 Option Award | 2021-02-16 6:00 pm | N/A 2031-02-11 | Oncternal Therapeutics Inc. | ONCT | VINCENT RICHARD G CFO | 280,000 | $0 | 280,000 (Direct) | View |
2021-02-11 Option Award | 2021-02-16 6:00 pm | N/A 2031-02-11 | Oncternal Therapeutics Inc. | ONCT | BREITMEYER JAMES B CEO | 750,000 | $0 | 750,000 (Direct) | View |
2021-02-11 Option Award | 2021-02-16 6:00 pm | N/A 2031-02-11 | Oncternal Therapeutics Inc. | ONCT | Kaufmann Gunnar F. Chief Scientific Officer | 253,000 | $0 | 253,000 (Direct) | View |
2021-02-11 Option Award | 2021-02-16 6:01 pm | N/A 2031-02-11 | Oncternal Therapeutics Inc. | ONCT | BILINSKY IGOR Chief Business Officer | 130,000 | $0 | 130,000 (Direct) | View |
2021-02-11 Option Award | 2021-02-16 6:01 pm | N/A 2031-02-11 | Oncternal Therapeutics Inc. | ONCT | MAZANET ROSEMARY Director | 20,000 | $0 | 20,000 (Direct) | View |
2021-01-27 Option Award | 2021-02-23 8:12 pm | N/A 2031-01-27 | Oncternal Therapeutics Inc. | ONCT | BREITMEYER JAMES B CEO | 7,000 | $0 | 7,000 (Indirect) | View |
2021-01-27 Option Award | 2021-02-23 8:12 pm | N/A 2031-02-21 | Oncternal Therapeutics Inc. | ONCT | BREITMEYER JAMES B CEO | 2,000 | $0 | 2,000 (Indirect) | View |
2021-03-18 Option Award | 2021-03-22 4:00 pm | N/A 2028-11-14 | Oncternal Therapeutics Inc. | ONCT | BREITMEYER JAMES B CEO | 63,295 | $0 | 105,492 (Direct) | View |